Past, present, and future of antifungal drug development

PK Shukla, P Singh, RK Yadav, S Pandey… - … Diseases of the …, 2018 - Springer
Fungi are eukaryotic, single cell or multicellular organisms which cause a wide range of
human diseases ranging from superficial skin to invasive life-threatening infections. Over the …

[PDF][PDF] Antifungal agents: Polyene, azole, antimetabolite, other and future agents

FA Malayeri, AA Rezaei, O Raiesi - J. Bas. Res. Med. Sci, 2018 - jbrms.medilam.ac.ir
Antifungals have always been considered as one of the astonishing discoveries of the 20th
century. This is correct, but the real marvel is the development of antifungal resistance in …

Discovery and development of antifungal compounds

M Kidwai, R Venkataramanan… - … -Anti-Infective Agents, 2003 - ingentaconnect.com
Antifungal agents constitute a major part of antiinfective drugs and have been in practice
since 16th century. Antifungal agents generally belong to the class of polyenes, azoles …

[HTML][HTML] Sources of antifungal drugs

G Vanreppelen, J Wuyts, P Van Dijck, P Vandecruys - Journal of Fungi, 2023 - mdpi.com
Due to their eukaryotic heritage, the differences between a fungal pathogen's molecular
makeup and its human host are small. Therefore, the discovery and subsequent …

Recent drug development and treatments for fungal infections

M Roy, S Karhana, M Shamsuzzaman… - Brazilian Journal of …, 2023 - Springer
Fungal infections are now becoming a hazard to individuals which has paved the way for
research to expand the therapeutic options available. Recent advances in drug design and …

Antifungals: mechanism of action and resistance, established and novel drugs

NH Georgopapadakou - Current opinion in microbiology, 1998 - Elsevier
Serious fungal infections, caused mostly by opportunistic species, are increasingly common
in immunocompromised and other vulnerable patients. The use of antifungal drugs, primarily …

Potential targets for the development of new antifungal drugs

H Su, L Han, X Huang - The journal of antibiotics, 2018 - nature.com
In recent years, incidences of invasive fungal infections have greatly increased, especially in
immunosuppressed patients, but most today's antifungal drugs are not completely effective …

New facets of antifungal therapy

YL Chang, SJ Yu, J Heitman, M Wellington, YL Chen - Virulence, 2017 - Taylor & Francis
Invasive fungal infections remain a major cause of morbidity and mortality in
immunocompromised patients, and such infections are a substantial burden to healthcare …

[HTML][HTML] New horizons in antifungal therapy

KM Pianalto, JA Alspaugh - Journal of Fungi, 2016 - mdpi.com
Recent investigations have yielded both profound insights into the mechanisms required by
pathogenic fungi for virulence within the human host, as well as novel potential targets for …

[HTML][HTML] Current antimycotics, new prospects, and future approaches to antifungal therapy

G Wall, JL Lopez-Ribot - Antibiotics, 2020 - mdpi.com
Fungal infections represent an increasing threat to a growing number of immune-and
medically compromised patients. Fungi are eukaryotic organisms and, as such, there is a …